Terri L Clemmons, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 110 E Mescalero Rd, Roswell, NM 88201 Phone: 505-623-1480 Fax: 505-622-3325 |
Kathleen Biggs, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3200 Mission Arch Dr, Roswell, NM 88201 Phone: 575-624-2583 |
Kori Dawn Stewart, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1107 S Atkinson Ave, Roswell, NM 88203 Phone: 575-578-4826 Fax: 575-578-4828 |
Tammie Singleton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3200 Mission Arch Dr, Roswell, NM 88201 Phone: 575-624-2583 |
Mary Esther Aragon, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1107 S Atkinson Ave, Roswell, NM 88203 Phone: 575-578-4826 Fax: 575-578-4828 |
Eloise E Granados, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1107 S Atkinson Ave, Roswell, NM 88203 Phone: 575-578-4826 |
News Archive
Cognitive impairment following a traumatic brain injury (TBI) is common, often adversely affecting quality of life for those 1.7 million Americans who experience a TBI each year. Researchers at the Center for BrainHealth at The University of Texas at Dallas have identified complex brain connectivity patterns in individuals with chronic phases of traumatic brain injury which may explain long term higher order cognitive function deficits.
AOptix Technologies, Inc., a leading provider of advanced optical technologies and products, today announced that Unisys, a worldwide information technology company, has become an AOptix strategic alliance partner.
People who grew up in single-parent families have lower levels of wellbeing and life satisfaction in adulthood, according to new research by the University of Warwick.
The American Society of Bariatric Physicians is concerned that the FDA recently rejected the weight-loss drug Contrave, contradicting the FDA advisory panel's recommendation for approval. The rejection of Contrave marks the third weight-loss drug to be rejected by the FDA in the past six months.
› Verified 3 days ago